tradingkey.logo
搜尋

Simulations Plus Inc

SLP
添加自選
18.230USD
-0.070-0.38%
收盤 07-31 16:00美東報價延遲15分鐘
368.70M總市值
虧損本益比TTM

關於 Simulations Plus Inc 公司

Simulations Plus, Inc. is a provider in the biopharma sector, offering advanced software and consulting services that enhance drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. It operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The Company operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. It delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.

Simulations Plus Inc簡介

公司代碼SLP
公司名稱Simulations Plus Inc
上市日期Jun 18, 1997
CEOO'Connor (Shawn M)
員工數量212
證券類型Ordinary Share
年結日Jun 18
公司地址800 Park Offices Drive, Suite 401
城市RESEARCH TRIANGLE PARK
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編27709
電話16617237723
網址https://www.simulations-plus.com/
公司代碼SLP
上市日期Jun 18, 1997
CEOO'Connor (Shawn M)

Simulations Plus Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.25M
-0.13%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
77.82K
--
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
17.17K
+12.33%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
14.59K
+14.51%
Mr. John A. Dibella
Mr. John A. Dibella
Chief Revenue Officer
Chief Revenue Officer
--
--
Dr. Daniel L. Weiner
Dr. Daniel L. Weiner
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--
Mr. Shawn M. O'Connor
Mr. Shawn M. O'Connor
Chief Executive Officer
Chief Executive Officer
--
--
Dr. Lisa Lavange
Dr. Lisa Lavange
Independent Director
Independent Director
--
--
Mr. William (Will) Frederick
Mr. William (Will) Frederick
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Dr. Jonathan Chauvin
Dr. Jonathan Chauvin
Co-Chief Product and Technology Officer
Co-Chief Product and Technology Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Hon. Walter S. Woltosz
Dr. Hon. Walter S. Woltosz
Independent Director
Independent Director
3.25M
-0.13%
Ms. Jill Fiedler-Kelly
Ms. Jill Fiedler-Kelly
Interim President - Services Solutions
Interim President - Services Solutions
77.82K
--
Ms. Sharlene Evans
Ms. Sharlene Evans
Independent Director
Independent Director
17.17K
+12.33%
Dr. John Kenneth Paglia, Ph.D.
Dr. John Kenneth Paglia, Ph.D.
Independent Director
Independent Director
14.59K
+14.51%
Mr. John A. Dibella
Mr. John A. Dibella
Chief Revenue Officer
Chief Revenue Officer
--
--
Dr. Daniel L. Weiner
Dr. Daniel L. Weiner
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
--
--

常見問題

Simulations Plus Inc的前五大股東是誰?

Simulations Plus Inc的前五大股東如下:Dr. Hon. Walter S. Woltosz

有多少機構持有Simulations Plus Inc(SLP)的股份?

截至2026Q1,共有432家機構持有Simulations Plus Inc的股份,合計持有的股份價值約為17.68M,占公司總股份的87.48% 。與2025Q4相比,機構持股有所增加,增幅為-4627215.00。

哪個業務部門對Simulations Plus Inc的收入貢獻最大?

在2026Q1,Consulting services業務部門對Simulations Plus Inc的收入貢獻最大,創收9.54M,占總收入的51.78% 。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有